Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in PI3K-Mutated Colorectal Cancer
NCT00390364Phase 2Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Oct 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in colorectal cancer (CRC), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Oct 2006; status: terminated.
02
Drugs
everolimus
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00390364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390364.